{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:49:23Z","timestamp":1777085363130,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bioorg.2020.104182","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T21:50:10Z","timestamp":1598478610000},"page":"104182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Synthesis of 3,4-dihydroquinolin-2(1H)-one derivatives with anticonvulsant activity and their binding to the GABAA receptor"],"prefix":"10.1016","volume":"103","author":[{"given":"Shiben","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuekun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104182_b0005","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.bmc.2010.03.010","article-title":"Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives","volume":"18","author":"Karakurt","year":"2010","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104182_b0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE Official Report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.bioorg.2020.104182_b0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1471-4159.2009.05982.x","article-title":"Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs","volume":"109","author":"Madsen","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2020.104182_b0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00007691-200202000-00015","article-title":"New antiepileptic drugs currently in clinical trials: is there a strategy in their development?","volume":"24","author":"Bialer","year":"2002","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.bioorg.2020.104182_b0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International union of pharmacology. LXX. subtypes of \u03b3-aminobutyric acid A receptors: classification on the basis of subunit composition, pharmacology, and function","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2020.104182_b0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1523\/JNEUROSCI.4639-11.2012","article-title":"Dihydromyricetin as a novel anti-alcohol intoxication medication","volume":"32","author":"Shen","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2020.104182_b0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.bioorg.2020.104182_b0040","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bmc.2014.12.016","article-title":"Novel agonists of benzodiazepine receptors: design, synthesis, binding assay and pharmacological evaluation of 1,2,4-triazolo[1,5-a]pyrimidinone and 3-amino-1,2,4-triazole derivatives","volume":"23","author":"Faizi","year":"2015","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104182_b0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejps.2018.12.018","article-title":"Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies","volume":"129","author":"Kapro\u0144","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2020.104182_b0050","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bmcl.2005.02.014","article-title":"Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles","volume":"15","author":"Zarghi","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104182_b0055","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1016\/j.arabjc.2020.03.009","article-title":"Synthesis and pharmacological evaluation of 3-[5-(aryl-[1,3,4]oxadiazole-2-yl]-piperidine derivatives as anticonvulsant and antidepressant agents","volume":"13","author":"Singh","year":"2020","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2020.104182_b0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejmech.2013.12.014","article-title":"Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones","volume":"73","author":"Deng","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104182_b0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"L\u20acoscher","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.bioorg.2020.104182_b0070","doi-asserted-by":"crossref","unstructured":"W. L\u20acoscher, D. H\u20aconack, C.P. Fassbender, B. Nolting, The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models, Epilepsy. Res., 8 (1991), 171-189.","DOI":"10.1016\/0920-1211(91)90062-K"},{"key":"10.1016\/j.bioorg.2020.104182_b0075","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jmgm.2008.12.004","article-title":"Molecular modeling of ligand-receptor interactions in GABAc receptor","volume":"27","author":"Osolodkin","year":"2009","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2020.104182_b0080","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/ja00467a001","article-title":"A hydrocarbon force field utilizing V1 and V2 torsional terms","volume":"99","author":"Allinger","year":"1977","journal-title":"J. A. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.104182_b0085","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1359-6446(03)02827-7","article-title":"In silico prediction of blood-brain barrier permeation","volume":"8","author":"Clark","year":"2003","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.bioorg.2020.104182_b0090","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrd2368","article-title":"Modelling of the blood-brain barrier in drug discovery and development","volume":"6","author":"Cecchelli","year":"2007","journal-title":"Nature Rev. Durg. Discov."},{"key":"10.1016\/j.bioorg.2020.104182_b0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1528-1157.1978.tb04507.x","article-title":"Antiepileptic drug development: II. Anticonvulsant drug screening","volume":"19","author":"Krall","year":"1978","journal-title":"Epilepsia"},{"key":"10.1016\/j.bioorg.2020.104182_b0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3949\/ccjm.51.2.293","article-title":"Antiepileptic drug development program","volume":"51","author":"Pote","year":"1984","journal-title":"Clev. Clin. J. Med."},{"key":"10.1016\/j.bioorg.2020.104182_b0105","unstructured":"H.S. White, J.H. Woodhead, K.S. Wilcox, J.P. Stables, H.J. Kupferberg, H.H. Wolf, Lippincott Williams & Wilkins Publishers. New York, 2002, 36."},{"key":"10.1016\/j.bioorg.2020.104182_b0110","first-page":"101","article-title":"Thin-layer chromatographic method for estimation of gamma-aminobutyric acid from brain","volume":"23","author":"Gokani","year":"1979","journal-title":"Indian. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.104182_b0115","first-page":"376","article-title":"A convenient method for determining serum and bile phosphatase activity","volume":"31","author":"King","year":"1934","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.bioorg.2020.104182_b0120","series-title":"Antiepileptic drugs","first-page":"99","article-title":"General principles: experimental selection, quantification and evaluation of antiepileptic drugs","author":"White","year":"1995"},{"key":"10.1016\/j.bioorg.2020.104182_b0125","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1016\/j.bmc.2010.06.064","article-title":"Design, synthesis and anticonvulsant activity of new N-mannich bases derived from spirosuccinimides and spirohydantoins","volume":"18","author":"Obniska","year":"2010","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104182_b0130","doi-asserted-by":"crossref","unstructured":"J.B.Jr. Hester, P. Von Voigtlander, 6-Aryl-4H-s-triazolo[4,3-a][1,4]ben-zodiazepines. Influence of 1-substitution on pharmacological activity. J. Med. Chem. 22 (1979), 1390-1398.","DOI":"10.1021\/jm00197a021"},{"key":"10.1016\/j.bioorg.2020.104182_b0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy. Res."},{"key":"10.1016\/j.bioorg.2020.104182_b0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nchembio.917","article-title":"Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands","volume":"8","author":"Richter","year":"2012","journal-title":"Nat. Chem. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820314796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820314796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:09:51Z","timestamp":1758614991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820314796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":28,"alternative-id":["S0045206820314796"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104182","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of 3,4-dihydroquinolin-2(1H)-one derivatives with anticonvulsant activity and their binding to the GABAA receptor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104182"}}